tm
Seeing Is Believing
tm
Seeing Is Believing
BOLT is currently covered by 2 analysts with an average price target of $67.06. This is a potential upside of $63.01 (1555.8%) from yesterday's end of day stock price of $4.05.
Bolt Biotherapeutics's activity chart (see below) currently has 12 price targets and 23 ratings on display. The stock rating distribution of BOLT is 50% HOLD and 50% BUY.
Analysts average stock forecasts to be materialized ratio is 8.33% with an average time for these price targets to be met of 1.5 days.
Highest price target for BOLT is $4, Lowest price target is $4, average price target is $4.
Most recent stock forecast was given by CHAD MESSER from LAKE STREET on 15-Aug-2025. First documented stock forecast 02-Mar-2021.
Currently out of the existing stock ratings of BOLT, 1 are a HOLD (50%), 1 are a BUY (50%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-Aug-2025
$4
$-0.3 (-6.98%)
6 months 26 days ago
(15-Aug-2025)
0/1 (0%)
$-1.15 (-22.33%)
Hold Since 15-May-2024
11 months 16 days ago
(25-Mar-2025)
0/3 (0%)
$126.4 (376.19%)
Hold Since 15-May-2024
$20
$15.7 (365.12%)
1 years 9 months 26 days ago
(15-May-2024)
1/2 (50%)
$3.4 (20.48%)
9
Hold Since 15-May-2024
$30
$25.7 (597.67%)
1 years 9 months 26 days ago
(15-May-2024)
0/2 (0%)
$13.4 (80.72%)
Hold Since 15-May-2024
$840
1 years 9 months 26 days ago
(15-May-2024)
0/1 (0%)
$206.8 (32.66%)
What is BOLT (Bolt Biotherapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on BOLT (Bolt Biotherapeutics) with a proven track record?
Which analyst has the current lower performing score on BOLT (Bolt Biotherapeutics) with a proven track record?
Which analyst has the most public recommendations on BOLT (Bolt Biotherapeutics)?
Which analyst is the currently most bullish on BOLT (Bolt Biotherapeutics)?
Which analyst is the currently most reserved on BOLT (Bolt Biotherapeutics)?
